Literature DB >> 16956962

Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells.

Keiko Kawai-Kowase1, Gary K Owens.   

Abstract

Smooth muscle cell (SMC) differentiation is an essential component of vascular development and these cells perform biosynthetic, proliferative, and contractile roles in the vessel wall. SMCs are not terminally differentiated and possess the ability to modulate their phenotype in response to changing local environmental cues. The focus of this review is to provide an overview of the current state of knowledge of molecular mechanisms involved in controlling phenotypic switching of SMC with particular focus on examination of processes that contribute to the repression of SMC marker genes. We discuss the environmental cues which actively regulate SMC phenotypic switching, such as platelet-derived growth factor-BB, as well as several important regulatory mechanisms required for suppressing expression of SMC-specific/selective marker genes in vivo, including those dependent on conserved G/C-repressive elements, and/or highly conserved degenerate CArG elements found in the promoters of many of these marker genes. Finally, we present evidence indicating that SMC phenotypic switching involves multiple active repressor pathways, including Krüppel-like zinc finger type 4, HERP, and ERK-dependent phosphorylation of Elk-1 that act in a complementary fashion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16956962     DOI: 10.1152/ajpcell.00394.2006

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  97 in total

Review 1.  Smooth muscle cell phenotypic switching in atherosclerosis.

Authors:  Delphine Gomez; Gary K Owens
Journal:  Cardiovasc Res       Date:  2012-03-08       Impact factor: 10.787

Review 2.  Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering.

Authors:  Jeffrey A Beamish; Ping He; Kandice Kottke-Marchant; Roger E Marchant
Journal:  Tissue Eng Part B Rev       Date:  2010-10       Impact factor: 6.389

3.  Store-operated Ca(2+) entry is not essential for PDGF-BB induced phenotype modulation in rat aortic smooth muscle.

Authors:  Craig A Emter; Douglas K Bowles
Journal:  Cell Calcium       Date:  2010-07       Impact factor: 6.817

Review 4.  miRNAs: roles and clinical applications in vascular disease.

Authors:  Md Saha Jamaluddin; Sarah M Weakley; Lidong Zhang; Panagiotis Kougias; Peter H Lin; Qizhi Yao; Changyi Chen
Journal:  Expert Rev Mol Diagn       Date:  2011-01       Impact factor: 5.225

Review 5.  Matrix metalloproteinases and descending aortic aneurysms: parity, disparity, and switch.

Authors:  Tom P Theruvath; Jeffrey A Jones; John S Ikonomidis
Journal:  J Card Surg       Date:  2011-09-29       Impact factor: 1.620

6.  Herbal formula HMC05 prevents human aortic smooth muscle cell migration and proliferation by inhibiting the ERK1/2 MAPK signaling cascade.

Authors:  Yun Hwan Kang; In Jun Yang; Heung Mook Shin
Journal:  J Nat Med       Date:  2011-08-11       Impact factor: 2.343

7.  A phospholipase Cγ1-activated pathway regulates transcription in human vascular smooth muscle cells.

Authors:  Irene Hunter; Keith S Mascall; Joe W Ramos; Graeme F Nixon
Journal:  Cardiovasc Res       Date:  2011-02-01       Impact factor: 10.787

Review 8.  Smooth muscle phenotype switching in blast traumatic brain injury-induced cerebral vasospasm.

Authors:  Eric S Hald; Patrick W Alford
Journal:  Transl Stroke Res       Date:  2013-11-07       Impact factor: 6.829

9.  CHIP represses myocardin-induced smooth muscle cell differentiation via ubiquitin-mediated proteasomal degradation.

Authors:  Ping Xie; Yongna Fan; Hua Zhang; Yuan Zhang; Mingpeng She; Dongfeng Gu; Cam Patterson; Huihua Li
Journal:  Mol Cell Biol       Date:  2009-02-23       Impact factor: 4.272

10.  Differentiation of bone marrow mesenchymal stem cells into the smooth muscle lineage by blocking ERK/MAPK signaling pathway.

Authors:  Kenichi Tamama; Chandan K Sen; Alan Wells
Journal:  Stem Cells Dev       Date:  2008-10       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.